Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.
Rujas E, Kucharska I, Tan YZ, Benlekbir S, Cui H, Zhao T, Wasney GA, Budylowski P, Guvenc F, Newton JC, Sicard T, Semesi A, Muthuraman K, Nouanesengsy A, Aschner CB, Prieto K, Bueler SA, Youssef S, Liao-Chan S, Glanville J, Christie-Holmes N, Mubareka S, Gray-Owen SD, Rubinstein JL, Treanor B, Julien JP.
Rujas E, et al. Among authors: julien jp.
Nat Commun. 2021 Jun 16;12(1):3661. doi: 10.1038/s41467-021-23825-2.
Nat Commun. 2021.
PMID: 34135340
Free PMC article.